GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFQ) » Definitions » Cyclically Adjusted PS Ratio

MedMen Enterprises (MedMen Enterprises) Cyclically Adjusted PS Ratio : 0.00 (As of Jun. 05, 2024)


View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises Cyclically Adjusted PS Ratio?

As of today (2024-06-05), MedMen Enterprises's current share price is $0.0001. MedMen Enterprises's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2023 was $0.36. MedMen Enterprises's Cyclically Adjusted PS Ratio for today is 0.00.

The historical rank and industry rank for MedMen Enterprises's Cyclically Adjusted PS Ratio or its related term are showing as below:

MMNFQ's Cyclically Adjusted PS Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.05
* Ranked among companies with meaningful Cyclically Adjusted PS Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

MedMen Enterprises's adjusted revenue per share data for the three months ended in Mar. 2023 was $0.020. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.36 for the trailing ten years ended in Mar. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


MedMen Enterprises Cyclically Adjusted PS Ratio Historical Data

The historical data trend for MedMen Enterprises's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises Cyclically Adjusted PS Ratio Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 8.50 0.71 0.64 0.18

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.18 0.11 0.05 0.04

Competitive Comparison of MedMen Enterprises's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's Cyclically Adjusted PS Ratio falls into.



MedMen Enterprises Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

MedMen Enterprises's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.0001/0.36
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMen Enterprises's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2023 is calculated as:

For example, MedMen Enterprises's adjusted Revenue per Share data for the three months ended in Mar. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=0.02/127.3478*127.3478
=0.020

Current CPI (Mar. 2023) = 127.3478.

MedMen Enterprises Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201304 0.002 98.107 0.003
201307 0.002 98.557 0.003
201310 0.002 98.536 0.003
201401 0.004 98.692 0.005
201404 0.001 100.023 0.001
201407 0.001 100.520 0.001
201410 0.014 100.176 0.018
201501 0.001 98.604 0.001
201504 0.001 99.824 0.001
201507 0.001 100.691 0.001
201510 0.001 100.346 0.001
201601 0.001 99.957 0.001
201604 0.001 100.947 0.001
201607 0.001 101.524 0.001
201610 0.005 101.988 0.006
201701 0.005 102.456 0.006
201704 0.000 103.167 0.000
201707 0.000 103.278 0.000
201710 -0.002 104.070 -0.002
201801 0.000 104.578 0.000
201804 0.000 105.708 0.000
201809 0.457 106.507 0.546
201812 0.396 105.998 0.476
201903 0.274 107.251 0.325
201906 0.209 108.070 0.246
201909 0.207 108.329 0.243
201912 0.200 108.420 0.235
202003 0.140 108.902 0.164
202006 0.079 108.767 0.092
202009 0.083 109.815 0.096
202012 0.067 109.897 0.078
202103 0.059 111.754 0.067
202106 0.056 114.631 0.062
202109 0.039 115.734 0.043
202112 0.030 117.630 0.032
202203 0.029 121.301 0.030
202206 0.026 125.017 0.026
202209 0.023 125.227 0.023
202212 0.023 125.222 0.023
202303 0.020 127.348 0.020

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


MedMen Enterprises  (OTCPK:MMNFQ) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


MedMen Enterprises Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises (MedMen Enterprises) Business Description

Traded in Other Exchanges
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.

MedMen Enterprises (MedMen Enterprises) Headlines

From GuruFocus

MedMen Provides Annual Filing Status Report

By Business Wire 11-17-2023

Q4 2019 Medmen Enterprises Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2020 Medmen Enterprises Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2021 Medmen Enterprises Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

MedMen Enterprises Announces Change of Auditor

By Business Wire Business Wire 03-23-2023

Q3 2019 Medmen Enterprises Inc Earnings Call Transcript

By GuruFocus Research 02-14-2024

MedMen Completes Sale of Florida Assets

By Business Wire Business Wire 08-22-2022

MedMen Announces Management and Board Changes

By Business Wire 01-24-2024